Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

FDA approves Leukine for H-ARS

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

FDA advisory committee recommends approval of Lucemyra

March 28, 2018

Novel metabotropic glutamate mGlu7 receptor agonists synthesized at Takeda

March 28, 2018

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

Institute of Radiation Medicine presents novel compounds protecting against radiation

March 19, 2018

Japanese researchers disclose PDE7 inhibitors

March 15, 2018

University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists

March 8, 2018

Anti-heroin vaccine demonstrates efficacy in rodents

March 7, 2018

Sublocade becomes available as first and only monthly injectable buprenorphine in the U.S.

March 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026